Hafner A, Bulyk ML, Jambhekar A, Lahav G. The multiple mechanisms that regulate p53 activity and cell fate. Nat Rev Mol Cell Biol. 2019;20(4):199–210.
CAS
PubMed
Google Scholar
Lane DP. Cancer p53, guardian of the genome. Nature. 1992;358(6381):15–6.
CAS
PubMed
Google Scholar
Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature. 1979;278(5701):261–3.
CAS
PubMed
Google Scholar
Linzer DI, Levine AJ. Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 1979;17(1):43–52.
CAS
PubMed
Google Scholar
Smith AE, Smith R, Paucha E. Characterization of different tumor antigens present in cells transformed by simian virus 40. Cell. 1979;18(2):335–46.
CAS
PubMed
Google Scholar
Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989;244(4901):217–21.
CAS
PubMed
Google Scholar
Kruse JP, Gu W. Modes of p53 regulation. Cell. 2009;137(4):609–22.
CAS
PubMed
PubMed Central
Google Scholar
Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 2006;13(6):951–61.
CAS
PubMed
Google Scholar
Farnebo M, Bykov VJ, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun. 2010;396(1):85–9.
CAS
PubMed
Google Scholar
Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387(6630):296–9.
CAS
PubMed
Google Scholar
Momand J, Wu HH, Dasgupta G. MDM2–master regulator of the p53 tumor suppressor protein. Gene. 2000;242(1–2):15–29.
CAS
PubMed
Google Scholar
Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 1998;92(6):725–34.
CAS
PubMed
Google Scholar
Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, et al. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell. 2004;5(5):465–75.
CAS
PubMed
Google Scholar
Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell. 2003;112(6):779–91.
CAS
PubMed
Google Scholar
Chen D, Kon N, Li M, Zhang W, Qin J, Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell. 2005;121(7):1071–83.
CAS
PubMed
Google Scholar
Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 2004;429(6987):86–92.
CAS
PubMed
Google Scholar
Huang Q, Raya A, DeJesus P, Chao SH, Quon KC, Caldwell JS, et al. Identification of p53 regulators by genome-wide functional analysis. Proc Natl Acad Sci U S A. 2004;101(10):3456–61.
CAS
PubMed
PubMed Central
Google Scholar
Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307–10.
CAS
PubMed
Google Scholar
Balint EE, Vousden KH. Activation and activities of the p53 tumour suppressor protein. Br J Cancer. 2001;85(12):1813–23.
CAS
PubMed Central
Google Scholar
Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 1997;90(4):595–606.
CAS
PubMed
Google Scholar
Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 2000;406(6792):207–10.
CAS
PubMed
Google Scholar
Samuels-Lev Y, O’Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 2001;8(4):781–94.
CAS
PubMed
Google Scholar
Nikolaev AY, Li M, Puskas N, Qin J, Gu W. Parc: a cytoplasmic anchor for p53. Cell. 2003;112(1):29–40.
CAS
PubMed
Google Scholar
Huang YF, Wee S, Gunaratne J, Lane DP, Bulavin DV. Isg15 controls p53 stability and functions. Cell Cycle. 2014;13(14):2200–10.
PubMed
Google Scholar
Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res. 2000;77:81–137.
CAS
PubMed
Google Scholar
Munoz-Fontela C, Pazos M, Delgado I, Murk W, Mungamuri SK, Lee SW, et al. p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J Immunol. 2011;187(12):6428–36.
CAS
PubMed
Google Scholar
Munoz-Fontela C, Macip S, Martinez-Sobrido L, Brown L, Ashour J, Garcia-Sastre A, et al. Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med. 2008;205(8):1929–38.
CAS
PubMed
PubMed Central
Google Scholar
Pampin M, Simonin Y, Blondel B, Percherancier Y, Chelbi-Alix MK. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol. 2006;80(17):8582–92.
CAS
PubMed
PubMed Central
Google Scholar
Lazo PA, Santos CR. Interference with p53 functions in human viral infections, a target for novel antiviral strategies? Rev Med Virol. 2011;21(5):285–300.
CAS
PubMed
Google Scholar
Li X, Zhang W, Liu Y, Xie J, Hu C, Wang X. Role of p53 in pseudorabies virus replication, pathogenicity, and host immune responses. Vet Res. 2019;50(1):9.
CAS
PubMed
PubMed Central
Google Scholar
Charni-Natan M, Solomon H, Rotter V. p53 and the viral connection: back into the future (double dagger). Cancers (Basel). 2018;10(6):178.
PubMed
Google Scholar
Sato Y, Tsurumi T. Genome guardian p53 and viral infections. Rev Med Virol. 2013;23(4):213–20.
CAS
PubMed
Google Scholar
Maruzuru Y, Fujii H, Oyama M, Kozuka-Hata H, Kato A, Kawaguchi Y. Roles of p53 in herpes simplex virus 1 replication. J Virol. 2013;87(16):9323–32.
CAS
PubMed
PubMed Central
Google Scholar
Maruzuru Y, Koyanagi N, Takemura N, Uematsu S, Matsubara D, Suzuki Y, et al. p53 is a host cell regulator during herpes simplex encephalitis. J Virol. 2016;90(15):6738–45.
CAS
PubMed
PubMed Central
Google Scholar
Casavant NC, Luo MH, Rosenke K, Winegardner T, Zurawska A, Fortunato EA. Potential role for p53 in the permissive life cycle of human cytomegalovirus. J Virol. 2006;80(17):8390–401.
CAS
PubMed
PubMed Central
Google Scholar
Xu D, Du Q, Han C, Wang Z, Zhang X, Wang T, et al. p53 signaling modulation of cell cycle arrest and viral replication in porcine circovirus type 2 infection cells. Vet Res. 2016;47(1):120.
PubMed
PubMed Central
Google Scholar
Yaseen MM, Yaseen MM, Alqudah MA. Broadly neutralizing antibodies: an approach to control HIV-1 infection. Int Rev Immunol. 2017;36(1):31–40.
CAS
PubMed
Google Scholar
Alqudah MAY, Yaseen MMM, Yaseen MMS. HIV-1 strategies to overcome the immune system by evading and invading innate immune system. HIV AIDS Rev. 2016;15(1):1–12.
Google Scholar
Yaseen MM, Abuharfeil NM, Darmani H. Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection. Open Biol. 2021;11(11):210216.
CAS
PubMed
PubMed Central
Google Scholar
Mohammad Yaseen M, Mohammad Abuharfeil N, Darmani H. T-cell evasion and invasion during HIV-1 infection: the role of HIV-1 Tat protein. Cell Immunol. 2022;377:104554.
CAS
PubMed
Google Scholar
Yaseen MM, Abuharfeil NM, Homa D. Anatomical distribution of myeloid-derived suppressor cells during HIV infection. Viral Immunol. 2021;10:673–8.
Google Scholar
Abuharfeil NM, Yaseen MM, Alsheyab FM. Harnessing antibody-dependent cellular cytotoxicity to control HIV-1 infection. ACS Infect Dis. 2019;5(2):158–76.
CAS
PubMed
Google Scholar
Yaseen MM, Abuharfeil NM, Yaseen MM, Shabsoug BM. The role of polymorphonuclear neutrophils during HIV-1 infection. Arch Virol. 2018;163(1):1–21.
CAS
PubMed
Google Scholar
Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, et al. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J. 2001;15(1):5–6.
CAS
PubMed
Google Scholar
Imbeault M, Ouellet M, Tremblay MJ. Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells. Retrovirology. 2009;6:5.
PubMed
Comments (0)